IP Verse

Molecules And Methods For Modulating Low Density Lipoprotein Receptor Related Protein 6 (Lrp6) - EP2567709

PATENT ANALYSIS

Patent Details

Grant Date
Dec 27, 2017
Company
NOVARTIS AG
Oppositions

BOEHRINGER INGELHEIM RCV GMBH & CO KG / BOEHRINGER INGELHEIM INTERNATIONAL GMBH

MERCK PATENT GMBH

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you